Metformin reduces morphine tolerance by inhibiting microglial-mediated neuroinflammation
Open Access
- 17 November 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Neuroinflammation
- Vol. 13 (1), 1-12
- https://doi.org/10.1186/s12974-016-0754-9
Abstract
Tolerance seriously impedes the application of morphine in clinical medicine. Thus, it is necessary to investigate the exact mechanisms and efficient treatment. Microglial activation and neuroinflammation in the spinal cord are thought to play pivotal roles on the genesis and maintaining of morphine tolerance. Activation of adenosine monophosphate-activated kinase (AMPK) has been associated with the inhibition of inflammatory nociception. Metformin, a biguanide class of antidiabetic drugs and activator of AMPK, has a potential anti-inflammatory effect. The present study evaluated the effects and potential mechanisms of metformin in inhibiting microglial activation and alleviating the antinociceptive tolerance of morphine. The microglial cell line BV-2 cells and mouse brain-derived endothelial cell line bEnd3 cells were used. Cytokine expression was measured using quantitative polymerase chain reaction. Cell signaling was assayed by western blot and immunohistochemistry. The antinociception and morphine tolerance were assessed in CD-1 mice using tail-flick tests. We found that morphine-activated BV-2 cells, including the upregulation of p38 mitogen-activated protein kinase (p38 MAPK) phosphorylation, pro-inflammatory cytokines, and Toll-like receptor-4 (TLR-4) mRNA expression, which was inhibited by metformin. Metformin suppressed morphine-induced BV-2 cells activation through increasing AMPK phosphorylation, which was reversed by the AMPK inhibitor compound C. Additionally, in BV-2 cells, morphine did not affect the cell viability and the mRNA expression of anti-inflammatory cytokines. In bEnd3 cells, morphine did not affect the mRNA expression of interleukin-1β (IL-1β), but increased IL-6 and tumor necrosis factor-α (TNF-α) mRNA expression; the effect was inhibited by metformin. Morphine also did not affect the mRNA expression of TLR-4 and chemokine ligand 2 (CCL2). Furthermore, systemic administration of metformin significantly blocked morphine-induced microglial activation in the spinal cord and then attenuated the development of chronic morphine tolerance in mice. Metformin significantly attenuated morphine antinociceptive tolerance by suppressing morphine-induced microglial activation through increasing AMPK phosphorylation.Funding Information
- National Natural Science Foundation of China (81471142)
- National Natural Science Foundation of China (CN) (81571069)
- China Postdoctoral Science Foundation Commission (2015M580473)
- Science and technology project of Jiangsu Provincial Administration of traditional Chinese Medicine (No. YB2015178)
- Foundation of Nanjing Medical University (No. 2014NJMUZD015)
This publication has 46 references indexed in Scilit:
- Expression of calcitonin gene-related peptide receptor subunits in cultured neurons following morphine treatmentNeuroscience Letters, 2013
- Microglia and Spinal Cord Synaptic Plasticity in Persistent PainNeural Plasticity, 2013
- Resveratrol Inhibits LPS-Induced MAPKs Activation via Activation of the Phosphatidylinositol 3-Kinase Pathway in Murine RAW 264.7 Macrophage CellsPLOS ONE, 2012
- Morphine activates neuroinflammation in a manner parallel to endotoxinProceedings of the National Academy of Sciences of the United States of America, 2012
- Morphine Induces Expression of Platelet-Derived Growth Factor in Human Brain Microvascular Endothelial Cells: Implication for Vascular PermeabilityPLOS ONE, 2011
- Metabotropic glutamate mGlu5 receptor-mediated serine phosphorylation of NMDA receptor subunit NR1 in hippocampal CA1 region after transient global ischemia in ratsEuropean Journal of Pharmacology, 2010
- Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balanceNature Medicine, 2010
- Immunity, Inflammation, and CancerCell, 2010
- Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major DepressionBiological Psychiatry, 2009
- COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesiaBritish Journal of Cancer, 2007